Jerry Shapiro

12.6k total citations · 3 hit papers
201 papers, 7.2k citations indexed

About

Jerry Shapiro is a scholar working on Urology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Jerry Shapiro has authored 201 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Urology, 106 papers in Dermatology and 29 papers in Pathology and Forensic Medicine. Recurrent topics in Jerry Shapiro's work include Hair Growth and Disorders (173 papers), Dermatologic Treatments and Research (53 papers) and Autoimmune Bullous Skin Diseases (28 papers). Jerry Shapiro is often cited by papers focused on Hair Growth and Disorders (173 papers), Dermatologic Treatments and Research (53 papers) and Autoimmune Bullous Skin Diseases (28 papers). Jerry Shapiro collaborates with scholars based in United States, Canada and Australia. Jerry Shapiro's co-authors include Kevin J. McElwee, Shabnam Madani, Kristen Lo Sicco, Eddy Wang, Adel Alsantali, Abdullah Alkhalifah, Nina Otberg, Lorena Avila, Lauren C. Strazzulla and Eileen Tan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Jerry Shapiro

194 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alopecia areata update

2010 451 citations Jerry Shapiro et al. Journal of the American Academy of Dermatology profile →
Alopecia areata

2017 346 citations Kristen Lo Sicco, Angela M. Christiano et al. Journal of the American Academy of Dermatology profile →
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial

2023 134 citations Brett King, Xingqi Zhang et al. profile →

Peers

Countries citing papers authored by Jerry Shapiro

Since Specialization

Citations

This map shows the geographic impact of Jerry Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Shapiro more than expected).

Fields of papers citing papers by Jerry Shapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Shapiro. The network helps show where Jerry Shapiro may publish in the future.

Co-authorship network of co-authors of Jerry Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Shapiro. A scholar is included among the top collaborators of Jerry Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Shapiro. Jerry Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review 2025 ·Journal of Clinical Medicine ·Juan Jimenez‐Cauhe, Kristen I. Lo Sicco, Jerry Shapiro, Ángela Hermosa‐Gelbard, Patrícia Burgos‐Blasco, Ana Melián-Olivera, Daniel Ortega‐Quijano, Cristina Pindado‐Ortega, (unknown), Daniel Asz‐Sigall, Sergio Vañó‐Galván	4
2	Improvement in Scalp Hair Appearance Following Treatment With a Non‐Ablative Fractional Laser: A Retrospective Observational Study 2025 ·Lasers in Surgery and Medicine ·Marc R. Avram, Dawn Queen, Jerry Shapiro, (unknown)	1
3	Low-Dose Oral Minoxidil during Chemotherapy: A Review of the Mechanism and Current Evidence 2025 ·Skin Appendage Disorders ·(unknown), (unknown), Alina Markova, Azael Freites‐Martínez, Ian Tattersall, Jerry Shapiro, Mario E. Lacouture, Kristen I. Lo Sicco	0
4	Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata 2024 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), Alison Lee, Theodora K. Karagounis, Jerry Shapiro, Michael Garshick, Kristen I. Lo Sicco	0
5	Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2 2024 ·Journal of the American Academy of Dermatology ·Brett King, Manabu Ohyama, Maryanne M. Senna, Jerry Shapiro, Yves Dutronc, Frédérick Durand, Chunyuan Liu, Guanglei Yu, (unknown), (unknown), Najwa Somani, Bianca Maria Piraccini	4
6	Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata 2024 ·British Journal of Dermatology ·Melissa Piliang, Jennifer Soung, Brett King, Jerry Shapiro, Lidia Rudnicka, Paul Farrant, Nina Magnolo, Bianca Maria Piraccini, Xin Luo, Robert Wołk, Deborah Woodworth, (unknown), (unknown)	14
7	Commonly used hair oils in the Black community: a narrative review in their use to treat androgenetic alopecia 2023 ·International Journal of Dermatology ·(unknown), (unknown), (unknown), (unknown), Jerry Shapiro, Kristen Lo Sicco, (unknown)	3
8	41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata 2023 ·Journal of the American Academy of Dermatology ·Jerry Shapiro, Justin Ko, Alexander Egeberg, Najwa Somani, Jakub Jedynak, Hitoe Torisu‐Itakura, Guanglei Yu, (unknown), Brittany G. Craiglow	1
9	A practical approach to the management of hair loss in patients with polycystic ovary syndrome 2023 ·Journal of the European Academy of Dermatology and Venereology ·Elizabeth J. Klein, (unknown), (unknown), Jerry Shapiro, Kristen Lo Sicco	2
10	A Plain Language Summary on Ritlecitinib Treatment for Adults and Adolescents with Alopecia Areata 2023 ·Immunotherapy ·Brett King, Xingqi Zhang, (unknown), Jacek C. Szepietowski, Jerry Shapiro, Charles Lynde, Natasha Atanaskova Mesinkovska, Samuel H. Zwillich, Lynne Napatalung, Dalia Wajsbrot, Rana Fayyad, Amy Freyman, Debanjali Mitra, Vivek S. Purohit, Rodney Sinclair, Robert Wołk	4
11	Platelet-Rich Plasma Applications, The Past 5 Years: A Review Article 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Jerry Shapiro, Kristen Lo Sicco, Michael Garshick	3
12	43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2 2023 ·Journal of the American Academy of Dermatology ·Brett King, Manabu Ohyama, Maryanne M. Senna, Jerry Shapiro, Yves Dutronc, Wen-Shuo Wu, Guanglei Yu, Yuxin Ding, (unknown), Bianca Maria Piraccini	1
13	Predictors of QOL in Patients with Alopecia Areata 2022 ·Journal of Investigative Dermatology ·Maryanne M. Senna, Justin Ko, (unknown), (unknown), Susan Ball, Emily Edson‐Heredia, Baojin Zhu, Jerry Shapiro	25
14	Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib 2021 ·JAAD Case Reports ·(unknown), (unknown), Jerry Shapiro, Kristen I. Lo Sicco	1
15	5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia 2020 ·Journal of the European Academy of Dermatology and Venereology ·John McCoy, Flavio Cadegiani, Carlos Gustavo Wambier, Sabina Herrera, Sergio Vañó‐Galván, Natasha Atanaskova Mesinkovska, Paulo Müller Ramos, Jerry Shapiro, Rodney Sinclair, Antonellá Tosti, Andy Goren	27
16	Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response 2020 ·Journal of the European Academy of Dermatology and Venereology ·Paulo Müller Ramos, John McCoy, Carlos Gustavo Wambier, Jerry Shapiro, Sergio Vañó‐Galván, Rodney Sinclair, Andy Goren	5
17	Forging the Future: 2018 Alopecia Areata Research Summit Summary Report 2020 ·Journal of Investigative Dermatology Symposium Proceedings ·(unknown), (unknown), Natasha Atanaskova Mesinkovska, Angela M. Christiano, Jerry Shapiro, David A. Norris	1
18	Primary cicatricial alopecia 2016 ·Journal of the American Academy of Dermatology ·Chantal Bolduc, Leonard C. Sperling, Jerry Shapiro	47
19	Clinical utility and validity of minoxidil response testing in androgenetic alopecia 2014 ·Dermatologic Therapy ·Andy Goren, Jerry Shapiro, Janet L. Roberts, John McCoy, (unknown), (unknown), Aldona Pietrzak, Torello Lotti	57
20	Evaluation and diagnosis of the hair loss patient 2014 ·Journal of the American Academy of Dermatology ·Thamer Mubki, Lidia Rudnicka, Małgorzata Olszewska, Jerry Shapiro	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact